FI955140A0 - Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeissä - Google Patents
Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeissäInfo
- Publication number
- FI955140A0 FI955140A0 FI955140A FI955140A FI955140A0 FI 955140 A0 FI955140 A0 FI 955140A0 FI 955140 A FI955140 A FI 955140A FI 955140 A FI955140 A FI 955140A FI 955140 A0 FI955140 A0 FI 955140A0
- Authority
- FI
- Finland
- Prior art keywords
- substd
- opt
- halo
- phenyl
- medicines
- Prior art date
Links
- SEPKUNXLGWMPHL-UHFFFAOYSA-N quinoxaline-2,3-dione Chemical class C1=CC=CC2=NC(=O)C(=O)N=C21 SEPKUNXLGWMPHL-UHFFFAOYSA-N 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 125000005843 halogen group Chemical group 0.000 abstract 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 125000002883 imidazolyl group Chemical group 0.000 abstract 2
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 125000004434 sulfur atom Chemical group 0.000 abstract 2
- 229910006069 SO3H Inorganic materials 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000003831 tetrazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4314591A DE4314591A1 (de) | 1993-04-28 | 1993-04-28 | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| DE19934344486 DE4344486A1 (de) | 1993-12-21 | 1993-12-21 | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| PCT/DE1994/000493 WO1994025469A1 (de) | 1993-04-28 | 1994-04-28 | Neue chinoxalindionderivative, deren herstellung und verwendung in arzneimitteln |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI955140L FI955140L (fi) | 1995-10-27 |
| FI955140A0 true FI955140A0 (fi) | 1995-10-27 |
Family
ID=25925529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI955140A FI955140A0 (fi) | 1993-04-28 | 1995-10-27 | Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeissä |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5750525A (no) |
| EP (2) | EP0696288B1 (no) |
| JP (1) | JP3530190B2 (no) |
| KR (1) | KR100293880B1 (no) |
| CN (1) | CN1053190C (no) |
| AT (1) | ATE196474T1 (no) |
| AU (1) | AU690550B2 (no) |
| CA (1) | CA2161425A1 (no) |
| CZ (1) | CZ290295B6 (no) |
| DE (1) | DE59409534D1 (no) |
| DK (1) | DK0696288T3 (no) |
| ES (1) | ES2150989T3 (no) |
| FI (1) | FI955140A0 (no) |
| GR (1) | GR3035053T3 (no) |
| HU (1) | HUT73676A (no) |
| IL (1) | IL109397A0 (no) |
| NO (2) | NO308902B1 (no) |
| NZ (1) | NZ265599A (no) |
| PL (1) | PL180332B1 (no) |
| PT (1) | PT696288E (no) |
| RU (1) | RU2140420C1 (no) |
| SK (1) | SK282851B6 (no) |
| WO (1) | WO1994025469A1 (no) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6057304A (en) * | 1992-10-26 | 2000-05-02 | Schering Aktiengesellschaft | Quinoxaline-phosphonic acid derivatives |
| ATE404201T1 (de) * | 1992-06-22 | 2008-08-15 | Univ California | Glycinrezeptorantagonisten und ihre verwendung |
| HU217837B (hu) * | 1994-05-18 | 2000-04-28 | EGIS Gyógyszergyár Rt. | Savamidok, ezeket tartalmazó gyógyászati készítmények és eljárás a hatóanyagok előállítására |
| GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
| CN1067387C (zh) * | 1994-09-27 | 2001-06-20 | 山之内制药株式会社 | 1,2,3,4－四氢喹喔啉二酮衍生物 |
| DE4439492A1 (de) * | 1994-10-25 | 1996-05-02 | Schering Ag | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| DE4439493A1 (de) * | 1994-10-25 | 1996-05-02 | Schering Ag | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| DE19519979A1 (de) * | 1995-05-24 | 1996-11-28 | Schering Ag | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| JPH11508902A (ja) * | 1995-07-10 | 1999-08-03 | ノバルティス・アクチエンゲゼルシャフト | 新規キノキサリン−およびキノキサリンアルカン−ホスホン酸 |
| DE19545251A1 (de) * | 1995-11-24 | 1997-05-28 | Schering Ag | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| TW448171B (en) * | 1996-06-06 | 2001-08-01 | Yamanouchi Pharma Co Ltd | Imidazole-substituted quinoxalinedione derivatives |
| ATE361909T1 (de) * | 1996-10-23 | 2007-06-15 | Warner Lambert Co | Substituierte gamma-aminobuttersäurederivate als arzneimittel |
| NZ334891A (en) * | 1996-10-24 | 2001-04-27 | Novartis Ag | Substituted aminoalkane phosphonic acids for treating block excitatory amino acid receptors related diseases |
| DE19728326A1 (de) * | 1997-06-27 | 1999-01-07 | Schering Ag | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| DE19737446A1 (de) * | 1997-08-22 | 1999-02-25 | Schering Ag | Verfahren zur Herstellung von Phosphonsäurederivaten |
| HUP0002853A3 (en) * | 1997-09-01 | 2001-12-28 | Kyorin Seiyaku Kk | 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them |
| US6015800A (en) * | 1997-09-03 | 2000-01-18 | Warner-Lambert Company | Substituted quinoxaline-2-ones as glutamate receptor antagonists |
| WO2000001376A2 (en) * | 1998-07-02 | 2000-01-13 | Eisai Co., Ltd | Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| CA2362385C (en) | 1999-02-15 | 2009-08-11 | Eisai Co., Ltd. | Heterodiazinon compound |
| FR2791982B1 (fr) * | 1999-04-06 | 2002-12-27 | Inst Nat Sante Rech Med | Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques. |
| CA2412172C (en) | 2000-06-12 | 2012-07-24 | Eisai Co., Ltd. | 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| GB0129260D0 (en) | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
| MY148809A (en) | 2004-07-06 | 2013-05-31 | Eisai R&D Man Co Ltd | Crystals of 1,2-dihydropyridine compound and their production process |
| CN100490835C (zh) * | 2004-12-14 | 2009-05-27 | 朱木林 | 一种治疗骨折的药物 |
| EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
| KR20210107644A (ko) | 2018-12-14 | 2021-09-01 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 1,2-디하이드로피리딘 화합물의 수성 기반 약학적 제형 |
| CN112142797B (zh) * | 2020-09-11 | 2023-07-14 | 江西师范大学 | 含磷的喹喔啉类化合物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO179551C (no) * | 1987-11-10 | 1996-10-30 | Novo Nordisk As | Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser |
| IL90315A0 (en) * | 1988-06-01 | 1989-12-15 | Ferrosan As | Imidazoquinoxaline compounds,their preparation and pharmaceutical compositions containing them |
| DK69790D0 (da) * | 1990-03-16 | 1990-03-16 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling af anvendelse |
| JP2550456B2 (ja) * | 1990-11-06 | 1996-11-06 | 山之内製薬株式会社 | 縮合ピラジン誘導体 |
| PT101004B (pt) * | 1991-10-26 | 1999-10-29 | Schering Ag | Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem |
| ATE404201T1 (de) * | 1992-06-22 | 2008-08-15 | Univ California | Glycinrezeptorantagonisten und ihre verwendung |
-
1994
- 1994-04-22 IL IL10939794A patent/IL109397A0/xx unknown
- 1994-04-28 JP JP52375194A patent/JP3530190B2/ja not_active Expired - Fee Related
- 1994-04-28 US US08/537,839 patent/US5750525A/en not_active Expired - Fee Related
- 1994-04-28 AU AU66755/94A patent/AU690550B2/en not_active Ceased
- 1994-04-28 EP EP94914313A patent/EP0696288B1/de not_active Expired - Lifetime
- 1994-04-28 CN CN94191917A patent/CN1053190C/zh not_active Expired - Fee Related
- 1994-04-28 PT PT94914313T patent/PT696288E/pt unknown
- 1994-04-28 HU HU9503078A patent/HUT73676A/hu unknown
- 1994-04-28 DE DE59409534T patent/DE59409534D1/de not_active Expired - Lifetime
- 1994-04-28 EP EP00250046A patent/EP1002796A3/de not_active Withdrawn
- 1994-04-28 CA CA002161425A patent/CA2161425A1/en not_active Abandoned
- 1994-04-28 NZ NZ265599A patent/NZ265599A/en unknown
- 1994-04-28 ES ES94914313T patent/ES2150989T3/es not_active Expired - Lifetime
- 1994-04-28 AT AT94914313T patent/ATE196474T1/de not_active IP Right Cessation
- 1994-04-28 WO PCT/DE1994/000493 patent/WO1994025469A1/de active IP Right Grant
- 1994-04-28 CZ CZ19952828A patent/CZ290295B6/cs not_active IP Right Cessation
- 1994-04-28 PL PL94317075A patent/PL180332B1/pl not_active IP Right Cessation
- 1994-04-28 KR KR1019950704705A patent/KR100293880B1/ko not_active Expired - Fee Related
- 1994-04-28 SK SK1318-95A patent/SK282851B6/sk unknown
- 1994-04-28 RU RU95120088A patent/RU2140420C1/ru not_active IP Right Cessation
- 1994-04-28 DK DK94914313T patent/DK0696288T3/da active
-
1995
- 1995-10-27 FI FI955140A patent/FI955140A0/fi not_active Application Discontinuation
- 1995-10-27 NO NO954315A patent/NO308902B1/no not_active IP Right Cessation
-
1997
- 1997-12-12 US US08/989,779 patent/US5955461A/en not_active Expired - Fee Related
-
2000
- 2000-03-28 NO NO20001604A patent/NO311428B1/no not_active IP Right Cessation
- 2000-12-12 GR GR20000402741T patent/GR3035053T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI955140A0 (fi) | Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeissä | |
| SE8200815L (sv) | Kemisk forening till anvendning som mellanprodukt vid framstellning av vissa triazolforeningar | |
| ATE137228T1 (de) | Aminocarbonsäure und derivate | |
| AR245447A1 (es) | Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas. | |
| ATE76640T1 (de) | 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| DK616388A (da) | Quinolincarboxylsyre-derivater og fysiologisk acceptable salte deraf med antibakteriel virkning | |
| NO933425L (no) | Nye aktive forbindelser | |
| NZ239894A (en) | Benzene, pyridinyl, and pyrimidinyl derivatives and medicaments | |
| BR9504456A (pt) | Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao | |
| SE8303987L (sv) | N-fenylpyrazolderivat anvendbara som herbicider | |
| GB997037A (en) | New hydrantoin derivatives | |
| ES8301196A1 (es) | Procedimiento de preparacion de un nuevo derivado de acido cinamoil-cinamico | |
| ES476408A1 (es) | Un procedimiento de preparacion de derivados de 2,4-tiazoli-dindiona. | |
| PL297368A1 (en) | Novel derivatives of 2h-benzo (b) pyrane substituted with aryl or n-heteroaryl at position 4, method of obtaining them and their applications as well as preparation containing these compounds | |
| NO306293B1 (no) | Benzoylguanidiner, deres anvendelse for fremstilling av legemiddel eller diagnostikum sÕvel som medikamenter inneholdende dem | |
| EE9500076A (et) | 1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena | |
| ES464729A1 (es) | Un procedimiento para la preparacion de benzisotiazolonas amino-alquil sustituidas. | |
| FI955670A (fi) | 2-aminobentseenisulfonihappo- ja 2-aminobentseenisulfonyyli kloridijohdannaiset, niiden valmistus ja käyttö synteesin välituotteina | |
| IL134036A0 (en) | Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them | |
| FR2341312A1 (fr) | Nouveaux derives du dithiepinno (1,4) (2,3-c) pyrrolle, leur preparation et les compositions qui les contiennent | |
| NL7602380A (en) | Topical antiinflammatory 1,2,4-triazine derivs - 3-chloro-5,6-bis (4-substd phenyl)-1,2,4-triazines | |
| FR2343479A1 (fr) | Nouvelles 3-chloro-5,6-diaryl-1,2,4-triazines et leur utilisation comme agents anti-inflammatoires locaux | |
| ES457262A1 (es) | Procedimiento de preparacion de nuevos derivados de ditie- pino (1,4) (2,3-c) pirrol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |
Free format text: METSO PAPER, INC. |